Hormone and pharmaceutical regulation of ASP production in 3T3-L1 adipocytes

Journal of Cellular Biochemistry

Volumn 109, Issue 5, 2010, Pages 896-905

  Gao, Ying ^a,b   Gauvreau, Danny ^a,c   Cianflone, Katherine ^a,c  

^a LAVAL UNIVERSITY   (Canada)

^b XINJIANG MEDICAL UNIVERSITY   (China)

^c UNIVERSITÉ LAVAL   (Canada)

Author keywords

Adipocyte; Adipokine secretion; Fatty acid uptake

Indexed keywords

ACYLATION STIMULATING PROTEIN; ADRENALIN; ANGIOTENSIN II; ATENOLOL; CHYLOMICRON; DEXAMETHASONE; FATTY ACID; LEPTIN; LIOTHYRONINE; METFORMIN; MEVINOLIN; PRECURSOR PROTEIN C3; PROGESTERONE; PROPRANOLOL; PROTEIN PRECURSOR; RIMONABANT; ROSIGLITAZONE; TESTOSTERONE; UNCLASSIFIED DRUG;

ADIPOCYTE; ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN 3T3; ENZYME ACTIVITY; FATTY ACID TRANSPORT; FRACTIONATION; HORMONAL REGULATION; HORMONE RELEASE; IN VITRO STUDY; LIPID METABOLISM; METABOLIC DISORDER; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; REGULATORY MECHANISM;

3T3-L1 CELLS; ADIPOCYTES; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CHYLOMICRONS; COMPLEMENT C3; FATTY ACIDS, NONESTERIFIED; HORMONES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; PHARMACEUTICAL PREPARATIONS; TRIGLYCERIDES;

EID: 77950393766     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22464     Document Type: Article

References (41)

1. Amri EZ, Teboul L, Vannier C, Grimaldi PA, Ailhaud G. 1996. Fatty acids regulate the expression of lipoprotein lipase gene and activity in preadipose and adipose cells. J Biochem 314:541-546.
2. Caprio M, Feve B, Claes A, Viengchareun S, Lombes M, Zennaro M. 2007. Pivotal role of the mineralocorticoid receptor in corticosteroid-induced adipogenesis. FASEB J 21:2185-2194.
3. Chernick SS, Spooner PM, Garrison MM, Scow RO. 1986. Effect of epinephrine and other lipolytic agents on intracellular lipolysis and lipoprotein lipase activity in 3T3-L1 adipocytes. J Lipid Res 27:286-294.
4. Choy LN, Rosen BS, Spiegelman BM. 1992. Adipsin and an endogenous pathway of complement from adipose cells. J Biol Chem 267:12736-12741.
5. Cianflone K, Xia ZN, Chen LY. 2003. Critical review of acylation-stimulating protein physiology in humans and rodents. Biochimi Biophys Acta 1609:127-143.
6. Ebeling P, Teppo AM, Koistinen HA, Viikari J, Ronnemaa T, Nissen M, Bergkulla S, Salmela P, Saltevo J, Koivisto VA. 1999. Troglitazone reduces hyperglycaemia and selectively acute-phase serum proteins in patients with Type II diabetes. Diabetologia 42:1433-1438.
7. Fu M, Sun T, Bookout AL, Downes M, Yu RT, Evans RM, Mangelsdorf DJ. 2005. A Nuclear Receptor Atlas: 3T3-L1 adipogenesis. Mol Endocrinol 19:2437-2450.
8. Fujita T, Fujioka T, Murakami T, Satomura A, Fuke Y, Matsumoto K. 2007. Chylomicron accelerates C3 tick-over by regulating the role of factor H, leading to overproduction of acylation stimulating protein. J Clin Lab Anal 21:14-23.
9. Galletti F, Fasano ML, Ferrara LA, Groppi A, Montagna M, Mancini M. 1989. Obesity and beta-blockers: Influence of body fat on their kinetics and cardiovascular effects. J Clin Pharmacol 29:212-216.
10. Gary-Bobo M, Elachouri G, Scatton B, Le Fur G, Oury-Donat F, Bensaid M. 2006. The cannabinoid CB1 receptor antagonist rimonabant (SR141716) inhibits cell proliferation and increases markers of adipocyte maturation in cultured mouse 3T3 F442A preadipocytes. Mol Pharmacol 69:471-478.
11. Giacchetti G, Faloia E, Mariniello B, Sardu C, Gatti C, Camilloni MA, Guerrieri M, Mantero F. 2002. Overexpression of the renin-angiotensin system in human visceral adipose tissue in normal and overweight subjects. Am J Hypertens 15:381-388.
12. Havel PJ. 2004. Update on adipocyte hormones: Regulation of energy balance and carbohydrate/lipid metabolism. Diabetes 53:S143-S151.
13. Jiang W, Miyamoto T, Kakizawa T, Sakuma T, Nishio S, Takeda T, Suzuki S, Hashizume K. 2004. Expression of thyroid hormone receptor alpha in 3T3-L1 adipocytes; triiodothyronine increases the expression of lipogenic enzyme and triglyceride accumulation. J Endocrinol 182:295-302.
14. Kalant D, Phélis S, Fielding BA, Frayn KN, Cianflone K, Sniderman AD. 2000. Increased postprandial fatty acid trapping in subcutaneous adipose tissue in obese women. J Lipid Res 41:1963-1968.
15. Kalant D, Maslowska M, Scantlebury T, Wang HW, Cianflone K. 2003. Control of lipogenesis in adipose tissue and the role of acylation stimulating protein. Can J Diab 27:154-171.
16. Kalant D, MacLaren R, Cui W, Samanta R, Monk PN, Laporte SA, Cianflone K. 2005. C5L2 is a functional receptor for acylation-stimulating protein. J Biol Chem 280:23936-23944.
17. Koistinen HA, Vidal H, Karonen SL, Dusserre E, Vallier P, Koivisto VA, Ebeling P. 2001. Plasma acylation stimulating protein concentration and subcutaneous adipose tissue C3 mRNA expression in nondiabetic and type 2 diabetic men. Arterioscler Thromb Vasc Biol 21:1034-1039.
18. MacLaren R, Kalant D, Cianflone K. 2007. The ASP receptor C5L2 is regulated by metabolic hormones associated with insulin resistance. Biochem Cell Biol 85:11-21.
19. Maslowska M, Scantlebury T, Germinario R, Cianflone K. 1997. Acute in vitro production of acylation stimulating protein in differentiated human adipocytes. J Lipid Res 38:1-11.
20. Matthaei S, Reibold JP, Hamann A, Benecke H, Haring HU, Greten H, Klein HH. 1993. In-vivo metformin treatment ameliorates insulin-resistance - Evidence for potentiation of insulin-induced translocation and increased functional-activity of glucose transporters in obese (Fa/Fa) zucker rat adipocytes. Endocrinology 133:304-311.
21. Mayes JS, Watson GH. 2004. Direct effects of sex steroid hormones on adipose tissues and obesity. Obes Rev 5:197-216.
22. Mulder AH, Tack CJ, Olthaar AJ, Smits P, Sweep FC, Bosch RR. 2005. Adrenergic receptor stimulation attenuates insulin-stimulated glucose uptake in 3T3-L1 adipocytes by inhibiting GLUT4 translocation. Am J Physiol Endocrinol Metab 289:E627-E633.
23. Nishio E, Tomiyama K, Nakata H, Watanabe Y. 1996. 3-Hydroxy-3-methyl- glutaryl coenzyme A reductase inhibitor impairs cell p4fferentiation in cultured adipogenic cells (3T3-L1). Eur J Pharmacol 301:203-206.
24. Oktenli C, Ozgurtas T, Dede M, Sanisoglu YS, Yenen MC, Yesilova Z, Kenar L, Kurt YG, Baser I, Smith J, Cianflone K. 2007. Metformin decreases circulating acylation-stimulating protein levels in polycystic ovary syndrome. Gynecol Endocrinol 23:710-715.
25. Paglialunga S, Fisette A, Yan Y, Deshaies Y, Brouillette JF, Pekna M, Cianflone K. 2008. Acylation-stimulating protein deficiency and altered adipose tissue in alternative complement pathway knockout mice. Am J Physiol Endocrinol Metab 294:E521-E529.
26. Prattes S, Hörl G, Hammer A, Blaschitz A, Graier WF, Sattler W, Zechner R, Steyrer E. 2000. Intracellular distribution and mobilization of unesterified cholesterol in adipocytes: Triglyceride droplets are surrounded by cholesterol- rich ER-like surface layer structures. J Cell Sci 113:2977-2989.
27. Sakoda H, Ogihara T, Anai M, Funaki M, Inukai K, Katagiri H, Fukushima Y, Onishi Y, Ono H, Fujishiro M, Kikuchi M, Oka Y, Asano T. 2000. Dexamethasone- induced insulin resistance in 3T3-L1 adipocytes is due to inhibition of glucose transport rather than insulin signal transduction. Diabetes 49:1700-1708.
28. Saleh J, Summers LK, Cianflone K, Fielding BA, Sniderman AD, Sniderman AD. 1998. Coordinated release of acylation stimulating protein (ASP) and triacylglycerol clearance by human adipose tissue in vivo in the postprandial period. J Lipid Res 39:884-891.
29. Saleh J, Cianflone K, Chaudhary T, Al Riyami H, Al Abri AR, Bayoumi R. 2007. Increased plasma acylation-stimulating protein correlates with hyperlipidemia at late gestation. Obesity 15:646-652.
30. Saleh J, Khanbashi M, Ai-Maarof M, Al Lawati M, Rizvi SG, Ciantlone K. 2009. Acylation-stimulating protein increases and correlates with increased progesterone levels during the luteal phase of the menstrual cycle. Eur J Endocrinol 160:301-307.
31. Scantlebury T, Maslowska M, Cianflone K. 1998. Chylomicron-specific enhancement of acylation stimulating protein and precursor protein C3 production in differentiated human adipocytes. J Biol Chem 273:20903-20909.
32. Scantlebury T, Sniderman AD, Cianflone K. 2001. Regulation by retinoic acid of acylation-stimulating protein and complement C3 in human adipocytes. Biochem J 356:445-452.
33. Schrauwen P, Hesselink MK, Jain M, Cianflone K. 2005. Acylation-stimulating protein: Effect of acute exercise and endurance training. Int J Obes (Lond) 29:632-638.
34. Tahiri Y, Karpe F, Tan GD, Cianflone K. 2007. Rosiglitazone decreases postprandial production of acylation stimulating protein in type 2 diabetics. Nutr Metab 4:11.
35. Wang P, Renes J, Bouwman F, Bunschoten A, Mariman E, Keijer J. 2007. Absence of an adipogenic effect of rosiglitazone on mature 3T3-L1 adipocytes: Increase of lipid catabolism and reduction of adipokine expression. Diabetologia 50:654-665.
36. Wen Y, Wang H, MacLaren R, Wu J, Lu H, Cianflone K. 2008. Palmitate and oleate induction of acylation stimulating protein resistance in 3T3-L1 adipocytes and preadipocytes. J Cell Biochem 104:391-401.
37. Wen Y, Wang HW, MacLaren R, Lu HL, Hu XF, Cianflone K. 2008. Sex steroid hormones induce acylation stimulating protein resistance in 3T3-L1 adipocytes. J Cell Biochem 105:404-413.
38. Wu Y, Zhang J, Wen Y, Wang H, Zhang M, Cianflone K. 2009. Increased acylation-stimulating protein, C-reactive protein, and lipid levels in young women with polycystic ovary syndrome. Fertil Steril 91:213-219.
39. Xu Y, Narayana SV, Volanakis JE. 2001. Structural biology of the alternative pathway convertase. Immunol Rev 180:123-135.
40. Yin XM, Tu L, Yang HQ. 2007. Effect of simavastatin on IL-6 and adiponectin secretion and mRNA expression in 3T3-L1 adipocytes. J Huazhong Univ Sci Technol 27:248-251.
41. Yu HY, Yang Y, Zhang MX, Lu HL, Zhang JH, Wang HW, Cianflone K. 2006. Thyroid status influence on adiponectin, acylation stimulating protein (ASP) and complement C3 in hyperthyroid and hypothyroid subjects. Nutr Metab 3:13.